Evidence map›Paper›PMID 35879128›Full record

ArticleGynecologic oncology2022

The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes.

Mario M Leitao, Qin C Zhou, Benny Brandt, Alexia Iasonos, Vasileios Sioulas, Katherine Lavigne Mager, Mark Shahin, Shaina Bruce, Destin R Black, Carrie G Kay and 27 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Gynecologic oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2025
    Article
  6. Review
  7. Article
  8. Advances in cervical cancer: current insights and future directions.Cancer communications (London, England) · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. The SHAPE trial: is good is good enough?Journal of gynecologic oncology · 2024
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Radical Hysterectomy for Early Stage Cervical Cancer.International journal of environmental research and public health · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 18 institutions in 2 countries.

Mario M LeitaoGynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, NY, United States of America; Department of Obstetrics and Gynecology, Weill Cornell Medical College, NY, NY, United States of America. Electronic address: leitaom@mskcc.org.
Qin C ZhouDepartment of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, NY, NY, United States of America.
Benny BrandtGynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, NY, United States of America.
Alexia IasonosDepartment of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, NY, NY, United States of America.
Vasileios SioulasGynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, NY, United States of America.
Katherine Lavigne MagerGynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, NY, United States of America.
Mark ShahinAbington Jefferson Hospital, Asplundh Cancer Pavilion, Sidney Kimmel Medical College of Thomas Jefferson University, Abington, PA, United States of America.
Shaina BruceAbington Jefferson Hospital, Asplundh Cancer Pavilion, Sidney Kimmel Medical College of Thomas Jefferson University, Abington, PA, United States of America.
Destin R BlackDepartment of Obstetrics and Gynecology, LSU Health Shreveport, Shreveport, LA, United States of America; Willis-Knighton Physician Network, Shreveport, LA, United States of America.
Carrie G KayWillis-Knighton Physician Network, Shreveport, LA, United States of America.
Meeli GandhiDepartment of Obstetrics and Gynecology, LSU Health Shreveport, Shreveport, LA, United States of America.
Maira QayyumDepartment of Obstetrics and Gynecology, LSU Health Shreveport, Shreveport, LA, United States of America.
Jennifer ScaliciUniversity of South Alabama Mitchell Cancer Institute, Mobile, AL, United States of America.
Nathaniel L JonesUniversity of South Alabama Mitchell Cancer Institute, Mobile, AL, United States of America.
Rajesh PaladuguUniversity of South Alabama Mitchell Cancer Institute, Mobile, AL, United States of America.
Jubilee BrownLevine Cancer Institute, Atrium Health, Charlotte, NC, United States of America.
R Wendel NaumannLevine Cancer Institute, Atrium Health, Charlotte, NC, United States of America.
Monica D LevineLevine Cancer Institute, Atrium Health, Charlotte, NC, United States of America.
Alberto MendivilGynecologic Oncology Associates, Hoag Cancer Center, Newport Beach, CA, United States of America.
Peter C LimCenter of Hope, University of Nevada School of Medicine, Reno, NV, United States of America.
Elizabeth KangCenter of Hope, University of Nevada School of Medicine, Reno, NV, United States of America.
Leigh A CantrellUniversity of Virginia, Department of OB/GYN, Division of Gynecologic Oncology, Charlottesville, VA, United States of America.
Mackenzie W SullivanUniversity of Virginia, Department of OB/GYN, Division of Gynecologic Oncology, Charlottesville, VA, United States of America.
Martin A MartinoLehigh Valley Cancer Institute, Allentown, PA, United States of America.
Melissa K KratzLehigh Valley Cancer Institute, Allentown, PA, United States of America.
Valentin KolevDepartment of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Shannon TomitaDepartment of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Charles A LeathUniversity of Alabama at Birmingham, Birmingham, AL, United States of America.
Teresa K L BoitanoUniversity of Alabama at Birmingham, Birmingham, AL, United States of America.
David W DooUniversity of Alabama at Birmingham, Birmingham, AL, United States of America.
Colleen FeltmateBrigham and Women's Hospital, Boston, MA, United States of America.
Ronan SugrueBrigham and Women's Hospital, Boston, MA, United States of America.
Alexander B OlawaiyeDepartment of Obstetrics, Gynecology and Reproductive Services, University of Pittsburgh School of Medicine, Magee-Women's Hospital of UPMC, Pittsburgh, PA, United States of America.
Ester GoldfeldDepartment of Obstetrics, Gynecology and Reproductive Services, University of Pittsburgh School of Medicine, Magee-Women's Hospital of UPMC, Pittsburgh, PA, United States of America.
Sarah E FergusonDivision of Gynecologic Oncology, Department of Surgical Oncology, Princess Margaret Cancer Centre/University Health Network, Toronto, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada.
Jessa SuhnerDepartment of Obstetrics, Gynecology and Reproductive Sciences, Mount Sinai West/Mount Sinai Morningside, New York, NY, United States of America.
Nadeem R Abu-RustumGynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, NY, United States of America; Department of Obstetrics and Gynecology, Weill Cornell Medical College, NY, NY, United States of America.
Memorial Sloan Kettering Cancer Center · USLevine Cancer Institute · USUniversity of Alabama at Birmingham · USUniversity of South Alabama · USBrigham and Women's Hospital · USIcahn School of Medicine at Mount Sinai · USLehigh Valley Hospital-Pocono · USLouisiana State University Health Sciences Center Shreveport · USThomas Jefferson University · USUniversity of Nevada, Reno · USUniversity of Virginia · USWillis-Knighton Cancer Center · USCornell University · USGynecologic Oncology Associates · USMagee-Womens Hospital · USMount Sinai Hospital · USUniversity of Pittsburgh · USUniversity of Toronto · CA

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

objectiveThe Laparoscopic Approach to Cervical Cancer (LACC) trial found that minimally invasive radical hysterectomy compared to open radical hysterectomy compromised oncologic outcomes and was associated with worse progression-free survival (PFS) and overall survival (OS) in early-stage cervical carcinoma. We sought to assess oncologic outcomes at multiple centers between minimally invasive (MIS) radical hysterectomy and OPEN radical hysterectomy.

methodsThis is a multi-institutional, retrospective cohort study of patients with 2009 FIGO stage IA1 (with lymphovascular space invasion) to IB1 cervical carcinoma from 1/2007-12/2016. Patients who underwent preoperative therapy were excluded. Squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinomas were included. Appropriate statistical tests were used.

resultsWe identified 1093 cases for analysis-715 MIS (558 robotic [78%]) and 378. OPEN procedures. The OPEN cohort had more patients with tumors >2 cm, residual disease in the hysterectomy specimen, and more likely to have had adjuvant therapy. Median follow-up for the MIS and OPEN cohorts were 38.5 months (range, 0.03-149.51) and 54.98 months (range, 0.03-145.20), respectively. Three-year PFS rates were 87.9% (95% CI: 84.9-90.4%) and 89% (95% CI: 84.9-92%), respectively (P = 0.6). On multivariate analysis, the adjusted HR for recurrence/death was 0.70 (95% CI: 0.47-1.03; P = 0.07). Three-year OS rates were 95.8% (95% CI: 93.6-97.2%) and 96.6% (95% CI: 93.8-98.2%), respectively (P = 0.8). On multivariate analysis, the adjusted HR for death was 0.81 (95% CI: 0.43-1.52; P = 0.5).

conclusionThis multi-institutional analysis showed that an MIS compared to OPEN radical hysterectomy for cervical cancer did not appear to compromise oncologic outcomes, with similar PFS and OS.

Indexed as

LaparoscopyUterine Cervical NeoplasmsDisease-Free SurvivalFemaleHumansHysterectomyMinimally Invasive Surgical ProceduresNeoplasm StagingRetrospective StudiesCervical cancerLACCLaparoscopic Approach to Cervical Cancer trialMinimally invasive radical hysterectomyRadical hysterectomy

Identifiers

PMID35879128
PMCPMC9933771
OpenAlexW4286515291

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.